CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Antibody TestWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug1579 Nebulized administration of RLF-100 or Placebo Wiki 1.00
drug2003 RLF-100 (aviptadil) Wiki 0.71
drug1822 Placebo Wiki 0.06

Correlated MeSH Terms (5)


Name (Synonyms) Correlation
D004417 Dyspnea NIH 0.38
D055370 Lung Injury NIH 0.21
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0002098 Respiratory distress HPO 0.38

There is one clinical trial.

Clinical Trials


1 Immune Status: Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Sample of the Eye Department (University Eye Hospital and Research Institute Tübingen)

A sequential combination of different antibodies test against SARS-CoV-2 is evaluated. The protocol included a rapid test and several ELISA tests within a defined cohort of healthcare workers.

NCT04446338 History of Covid-19, Seroprevalence Diagnostic Test: Antibody Test

Primary Outcomes

Description: Rate of anti-SARS-CoV-2 Antibodies

Measure: Seroprevalence

Time: through study completion, maximum of one year

Secondary Outcomes

Description: Kappa statistics

Measure: Agreement of the test results and questionnaire

Time: through study completion, maximum of one year

Measure: Positive predictive / negative values of the tests applied

Time: through study completion, maximum of one year


No related HPO nodes (Using clinical trials)